Related Experiment Videos

Discrepancy between first-dose converting enzyme inhibition at rest and subsequent inhibition during exercise in

P C Kirlin1, C Dansby, C K Laird

  • 1Department of Medicine, College of Human Medicine, Michigan State University, East Lansing 48824.

Insights

Low-dose angiotensin-converting enzyme (ACE) inhibitors may not fully block the renin-angiotensin system during exercise in heart failure. Higher doses are needed for complete blockade during physical activity after chronic therapy.

Area of Science:

  • Cardiology
  • Pharmacology
  • Physiology

Background:

  • Angiotensin-converting enzyme (ACE) inhibitors are standard therapy for chronic heart failure.
  • Complete blockade of the renin-angiotensin system (RAS) is a therapeutic goal in heart failure management.
  • The extent of RAS blockade by ACE inhibitors, particularly at low doses and during exercise, requires further elucidation.

Purpose of the Study:

  • To compare the hemodynamic and hormonal effects of initial low-dose versus higher-dose ACE inhibitors (lisinopril or captopril) at rest.
  • To assess the impact of chronic ACE inhibitor therapy on these responses during treadmill exercise testing in patients with chronic heart failure.
  • To determine if initial low-dose ACE inhibition achieves complete RAS blockade during exercise.

Main Methods:

  • Nine patients with chronic heart failure underwent hemodynamic and hormonal assessments at rest and during treadmill exercise.
  • Measurements included systemic arterial pressure, heart rate, plasma renin activity (PRA), and plasma aldosterone concentration (PAC).
  • Patients received initial low-dose and higher-dose ACE inhibitors, followed by chronic therapy for at least 4 weeks.

Main Results:

  • At rest, both low and higher initial doses of ACE inhibitors produced similar changes in systemic arterial pressure, PRA, and PAC.
  • During exercise after chronic therapy, dose-dependent increases in PRA and decreases in PAC were observed.
  • No significant differences in exercise systemic arterial pressure or heart rate were noted between dose groups during chronic therapy.

Conclusions:

  • Initial low-dose ACE inhibition effectively blocks the RAS at rest.
  • Higher doses of ACE inhibitors are necessary for complete RAS blockade during exercise in patients with chronic heart failure on chronic therapy.
  • These findings highlight the importance of dose titration for optimal RAS blockade in heart failure management during physical exertion.

Related Concept Videos